van der Wal Dianne E, Rey Gomez Laura M, Hueneburg Thomas, Linnane Claire, Marks Denese C
Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Transfusion. 2022 Jun;62(6):1289-1301. doi: 10.1111/trf.16891. Epub 2022 Apr 25.
Platelets shed platelet microparticles (PMP) when activated or stored. As the removal of sialic acid (desialylation) promotes platelet uptake and clearance from the circulation, similar mechanisms for PMP uptake were hypothesized. The aim of the study was to investigate the role of surface glycans in the in vitro uptake of PMP from stored platelet components.
Apheresis platelet components were stored in 40% plasma/60% SSP+ and sampled on day 1, 5, and 7 post-collection. PMP were characterized by staining with annexin-V (AnV) for phosphatidylserine (PS)-exposure, CD41 antibody, and fluorescently labeled glycan-binding lectins using flow cytometry. The procoagulant function of PMP following desialylation by neuraminidase treatment was assessed by AnV binding and a procoagulant phospholipid assay. PMP were isolated and stained with Deep Red, and phagocytosis by HepG2 cells was measured. Isolated PMP were deglycosylated with neuraminidase and galactosidase to assess the involvement of glycans in mediating phagocytosis.
While the overall platelet surface glycan profile was unchanged during storage, PS platelets were sialylated, indicating different glycoproteins were changed. In contrast, sialic acid was removed from PS and CD41 PMP, which specifically lost α-2,3-linked sialic acid during platelet storage. PMP were phagocytized by HepG2 cells, and PMP from platelets stored for 7 days were phagocytized to a lesser extent than on day 1. Desialylation by neuraminidase induced PS-exposure on PMP, decreased PPL clotting time, and increased PMP phagocytosis.
PMP glycans change during platelet storage. Desialylation influences the procoagulant function of PMP and phagocytosis by HepG2 cells.
血小板在激活或储存时会释放血小板微粒(PMP)。由于唾液酸的去除(去唾液酸化)会促进血小板从循环中摄取和清除,因此推测PMP摄取存在类似机制。本研究的目的是探讨表面聚糖在体外从储存的血小板成分中摄取PMP的作用。
单采血小板成分储存在40%血浆/60% SSP+中,并在采集后第1、5和7天取样。使用流式细胞术,通过用膜联蛋白-V(AnV)染色检测磷脂酰丝氨酸(PS)暴露、CD41抗体以及荧光标记的聚糖结合凝集素对PMP进行表征。通过AnV结合和促凝磷脂测定评估经神经氨酸酶处理去唾液酸化后PMP的促凝功能。分离PMP并用深红色染色,测量HepG2细胞的吞噬作用。用神经氨酸酶和半乳糖苷酶对分离的PMP进行去糖基化,以评估聚糖在介导吞噬作用中的作用。
虽然储存期间血小板表面聚糖的总体概况未发生变化,但PS血小板被唾液酸化,表明不同的糖蛋白发生了变化。相比之下,PS和CD41 PMP中的唾液酸被去除,在血小板储存期间特异性地失去了α-2,3-连接的唾液酸。PMP被HepG2细胞吞噬,储存7天的血小板来源的PMP吞噬程度低于第1天。神经氨酸酶去唾液酸化诱导PMP上的PS暴露,缩短PPL凝血时间,并增加PMP吞噬作用。
血小板储存期间PMP聚糖发生变化。去唾液酸化影响PMP的促凝功能和HepG2细胞的吞噬作用。